v3.25.2
Segment Information - Reconciliation of Segment Adjusted EBITDA to Net income (loss) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information            
Revenues $ 621.4   $ 650.3   $ 1,215.1 $ 1,271.5
People-related costs (204.0)   (210.7)   (409.7) (427.0)
Royalties and other product costs (79.1)   (86.1)   (161.0) (178.4)
Technology costs (39.2)   (40.4)   (78.1) (78.2)
Outside service costs (17.0)   (18.2)   (34.4) (36.7)
Other costs (20.5)   (20.5)   (37.1) (40.5)
Adjusted EBITDA 261.6   274.4   494.8 510.7
Provision (benefit) for income taxes (12.3)   6.8   (31.1) (8.2)
Depreciation and amortization (190.9)   (184.4)   (376.3) (363.8)
Interest expense, net (66.6)   (71.1)   (130.9) (141.3)
Royalties and other product costs (18.5)   (18.9)   (29.6) (34.3)
Goodwill and intangible asset impairments 0.0   (302.8)   0.0 (302.8)
Mark to market gain (loss) on financial instruments 0.0   0.0   0.0 5.2
Transaction related costs (8.1)   (3.1)   (14.4) (7.5)
Other (27.9)   (4.5)   (54.4) (27.1)
Net income (loss) (72.0) $ (103.9) (304.3) $ (75.0) (175.9) (379.3)
Restructuring and other impairments (9.3)   (0.7)   (34.0) (10.2)
Academia & Government            
Segment Reporting Information            
Revenues 318.5   344.5   621.2 662.2
People-related costs (84.1)   (90.5)   (170.3) (182.7)
Royalties and other product costs (50.4)   (59.9)   (105.5) (120.9)
Technology costs (20.0)   (21.3)   (39.6) (41.3)
Outside service costs (8.8)   (10.1)   (17.9) (20.6)
Other costs (10.4)   (10.6)   (19.3) (21.1)
Adjusted EBITDA 144.8   152.1   268.6 275.6
Restructuring and other impairments (4.3)   0.2   (16.6) (3.7)
Intellectual Property            
Segment Reporting Information            
Revenues 202.5   201.6   395.2 402.5
People-related costs (73.7)   (72.0)   (146.4) (145.3)
Royalties and other product costs (19.3)   (16.7)   (37.3) (38.8)
Technology costs (12.6)   (12.0)   (24.9) (23.4)
Outside service costs (5.2)   (5.0)   (10.9) (9.8)
Other costs (7.1)   (6.8)   (12.3) (13.0)
Adjusted EBITDA 84.6   89.1   163.4 172.2
Restructuring and other impairments (1.8)   (0.4)   (8.3) (3.0)
Life Sciences & Healthcare            
Segment Reporting Information            
Revenues 100.4   104.2   198.7 206.8
People-related costs (46.2)   (48.2)   (93.0) (99.0)
Royalties and other product costs (9.4)   (9.5)   (18.2) (18.7)
Technology costs (6.6)   (7.1)   (13.6) (13.5)
Outside service costs (3.0)   (3.1)   (5.6) (6.3)
Other costs (3.0)   (3.1)   (5.5) (6.4)
Adjusted EBITDA 32.2   33.2   62.8 62.9
Restructuring and other impairments $ (3.2)   $ (0.5)   $ (9.1) $ (3.5)